Gov. Andrew M. Cuomo has signed a bill enabling OSI Pharmaceuticals Inc. to expand its operations at Farmingdale State College. The legislation, which passed with overwhelming support in the State Senate and Assembly, establishes the boundaries for the college's Broad Hollow Bioscience Park at 38.5 acres and allows for the construction of a third building. This new structure will house start-up companies while OSI expands into an existing building. The move is expected to create 135 jobs at the college, bolstering Long Island's biotechnology sector.
State senators have approved a bill to expand the business incubator at Farmingdale State College, a significant move aimed at boosting the local biotechnology sector. The legislation designates 38.5 acres for the Broad Hollow Bioscience Park and facilitates the construction of a third building to house start-up companies, with OSI Pharmaceuticals expanding into an existing second building. OSI, known for its lung cancer drug Tarceva, plans to create approximately 135 new jobs. The bill also exempts park tenants from state construction and procurement laws, simplifying development processes. This expansion is expected to drive economic growth and innovation in Long Island's biotechnology industry.